RT by @ECDC_EU: Excellent news for #lunghealth!
Thanks to a new weekly surveillance summary for #influenza, #RSV and #COVID19, we will now have cohesive data on #respiratory virus in Europe: https://erviss.org/
The #ERVISS will inform vaccination and care planning to #KeepBreathing
🐦🔗: https://nitter.cz/EuroLungHealth/status/1717497284580069810#m
[2023-10-26 11:03 UTC]
R to @ECDC_EU: Where available, #ERVISS also presents laboratory testing and virus characterisation data for circulating pathogens, such as determining virus type/subtype/strain, susceptibility to antivirals and similarity to available vaccines.
Click to have a look: https://erviss.org
🐦🔗: https://nitter.cz/ECDC_EU/status/1717166327952007223#m
[2023-10-25 13:08 UTC]
R to @ECDC_EU: By providing a concise summary of the #epidemiological and #virological situation for respiratory virus infections, #ERVISS supports #PublicHealth decision-makers to take timely, well-informed decisions to limit the impact on healthcare systems and the wider public.
🐦🔗: https://nitter.cz/ECDC_EU/status/1717166324508405937#m
[2023-10-25 13:08 UTC]
R to @ECDC_EU: #ERVISS is a response to a call to develop a standard approach to jointly monitor #influenza, #RSV and #SARSCoV2, as these viruses are expected to co-circulate in the coming years.
The overviews will be published on a weekly basis.
🐦🔗: https://nitter.cz/ECDC_EU/status/1717166331106140399#m
[2023-10-25 13:08 UTC]
ECDC and World Health Organization (WHO) Regional Office for Europe have jointly developed the European Respiratory Virus Surveillance Summary (ERVISS), an interactive surveillance data dashboard for influenza, respiratory syncytial virus (RSV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that also features a weekly epidemiological summary.
ECDC